Clinical Outcomes of Remote Training for Advanced Diabetes Technologies During the COVID-19 Pandemic

J Diabetes Sci Technol. 2022 Jan;16(1):264-265. doi: 10.1177/19322968211050653. Epub 2021 Oct 9.
No abstract available

Keywords: Continuous Glucose Monitoring; Continuous Subcutaneous Insulin Infusion; hybrid artificial pancreas; telemedicine; type 1 diabetes.

Publication types

  • Letter

MeSH terms

  • Blood Glucose
  • Blood Glucose Self-Monitoring
  • COVID-19*
  • Diabetes Mellitus, Type 1* / drug therapy
  • Humans
  • Hypoglycemic Agents / therapeutic use
  • Insulin / therapeutic use
  • Insulin Infusion Systems
  • Pandemics
  • SARS-CoV-2
  • Telemedicine*

Substances

  • Blood Glucose
  • Hypoglycemic Agents
  • Insulin